Ortho Regenerative Technologies Closes $2.5 Million Private Placement

Quebec-based Ortho Regenerative Technologies closed a non-brokered private placement of units. The company issued 7.7 million units at a purchase price of $0.32 per unit for total gross proceeds of $2.47 million.

The net proceeds will fund ongoing value creation activities including:

securing FDA approval to start U.S. clinical...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us